← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 31, 2013Last known activity
Oct 15, 2024
Timeline
2010s
- Apr 28, 2015
Manna Research— Acquired
Drugs by trial phase (13 distinct, 9 trials)
Phase 4 (10 own, 0 via acquisition)
Phase 3 (1 own, 1 via acquisition)
Phase 2 (0 own, 1 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (12)
- NCT06217302CollaboratorPhase 3Oct 15, 2024
- NCT03813316Overall official - principal investigatorPhase 4May 1, 2019
- NCT03813316Lead sponsorPhase 4May 1, 2019
- NCT03819790Lead sponsorPhase 4Oct 2, 2018
- NCT03838783Reponsible party - principal investigatorPhase 4May 15, 2018
- NCT03838783Lead sponsorPhase 4May 15, 2018
- NCT03057470Lead sponsorPhase 4May 1, 2016
- NCT02682680Lead sponsorPhase 4Jan 1, 2016
- NCT02682680Reponsible party - principal investigatorPhase 4Jan 1, 2016
- NCT02540486Lead sponsorN/ADec 31, 2013
- NCT02540486Reponsible party - principal investigatorN/ADec 31, 2013
- NCT02540486Overall official - principal investigatorN/ADec 31, 2013
Details
- Founded
- Toronto, CA
- Last known activity
- Oct 15, 2024